NCT05705336View on ClinicalTrials.gov

Clinical Trial Analyzing the Efficacy of Oral Administration of Tranexamic Acid in Spine Surgery.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

January 1, 2022

Conditions
Tranexamic Acid (TXA)Prospective StudyEvidence-based MedicineRandomized Controlled Trial
Interventions
DRUG

Tranexamic Acid Oral Product

Single dose of 1950 mg (3 tablets of 650 mg) was administered orally 2 hours before the surgical incision.

DRUG

Placebo pills

Single dose of 3 standard placebo pills administered orally 2 hours before the surgical incision.

Trial Locations (1)

14389

Alejandro Reyes Sánchez, Mexico City

All Listed Sponsors
lead

Alejandro Reyes Sánchez

OTHER_GOV

NCT05705336 - Clinical Trial Analyzing the Efficacy of Oral Administration of Tranexamic Acid in Spine Surgery. | Biotech Hunter | Biotech Hunter